Clinical Trial Update: Genomic Risk in Retroperitoneal Sarcoma

View source ↗

Summary

A clinical trial update announcing ongoing recruitment for a study investigating genomic risk in retroperitoneal sarcoma, sponsored by Fox Chase Cancer Center.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retroperitoneal Liposarcoma
• Soft Tissue Sarcoma

Snippet

Sponsor: Fox Chase Cancer Center | Conditions: Retroperitoneal Liposarcoma, Soft Tissue Sarcoma | Status: RECRUITING